European Archives - Page 751 of 1618 - European Medical Journal

Ustekinumab: A Promising Early Treatment for Type 1 Diabetes

Researchers at Cardiff University have identified that Ustekinumab may effectively manage the early stages of Type 1 diabetes in children and adolescents.

Childhood Type 1 Diabetes is Linked to Increased Mental Health Risks

According to recent findings, individuals who develop Type 1 diabetes face a heightened risk of mental health disorders.

Faecal Test Screening Significantly Lowers Colorectal Cancer Mortality

New data has revealed that screening for colorectal cancer using faecal immunochemical tests is significantly associated with a reduction in mortality rates.

Early Hypoalbuminemia Predicts Severe Outcomes in Acute Pancreatitis

Researchers have identified that hypoalbuminemia within the first 24 hours of hospital admission for acute pancreatitis could serve as a significant predictor of adverse outcomes.

Sugary Beverage Consumption During Pregnancy Linked with Adverse Outcomes

New study found a strong association between the consumption of sugary and sweetened beverages during pregnancy and adverse health outcomes for both mothers and their babies

COVID-19 Infection Does Not Affect Pregnancy Outcomes in Frozen Embryo Transfers

A study investigated whether COVID-19 infections influence embryo implantation and early development in patients undergoing frozen embryo transfer.

Western Diet May Heighten Inflammatory Bowel Disease and Colon Cancer Risk

New research reveals the impact of diet on the composition and function of our gut microbiome.

COVID-19 Linked to Accelerated Type 1 Diabetes Onset in Presymptomatic Youth

COVID-19 infection has been associated with a rapid progression to clinical type 1 diabetes in young individuals with presymptomatic disease, according to a recent study.

Multiple Myeloma Therapy Outcome Predicted Using Simple Blood Test

Study shows that monitoring absolute lymphocyte count after BCMA CAR-T therapy in relapsed or refractory multiple myeloma can predict treatment outcomes.

Long-Term Lung Damage Persists in Over 90% of COVID-19 Patients

A new study found that 92% of patients hospitalised for COVID-19 still have lung lesions two years after discharge.